Nippon India NIFTY Pharma ETF
Monthly portfolio · 24 months through Sep-2026
compared to Aug-2026 · as on September 30,2026
Holdings
20
Scheme AUM
₹1,736 cr
New
0
Exited
0
Increased
19
Reduced
1
| Change | Security | Industry / Rating | Quantity | Δ Qty | % to NAV | Δ % | Market value |
|---|---|---|---|---|---|---|---|
| Increased | Sun Pharmaceutical Industries Limited INE044A01036 | Pharmaceuticals & Biotechnology | 18,64,349 | +23,565 | 19.50% | -1.25pp | ₹339 cr |
| Increased | Divi's Laboratories Limited INE361B01024 | Pharmaceuticals & Biotechnology | 2,23,780 | +2,839 | 11.97% | +0.09pp | ₹208 cr |
| Increased | Laurus Labs Limited INE947Q01028 | Pharmaceuticals & Biotechnology | 6,85,768 | +9,367 | 7.82% | +0.46pp | ₹136 cr |
| Increased | Cipla Limited INE059A01026 | Pharmaceuticals & Biotechnology | 9,90,875 | +12,685 | 7.68% | -0.15pp | ₹133 cr |
| Increased | Dr. Reddy's Laboratories Limited INE089A01031 | Pharmaceuticals & Biotechnology | 10,73,802 | +14,091 | 7.62% | +0.67pp | ₹132 cr |
| Increased | Torrent Pharmaceuticals Limited INE685A01028 | Pharmaceuticals & Biotechnology | 2,59,104 | +4,105 | 7.16% | -0.18pp | ₹124 cr |
| Increased | Lupin Limited INE326A01037 | Pharmaceuticals & Biotechnology | 4,27,699 | +5,525 | 5.00% | -0.25pp | ₹86.83 cr |
| Increased | Aurobindo Pharma Limited INE406A01037 | Pharmaceuticals & Biotechnology | 4,86,612 | +5,426 | 4.69% | — | ₹81.36 cr |
| Increased | Glenmark Pharmaceuticals Limited INE935A01035 | Pharmaceuticals & Biotechnology | 2,65,105 | +3,356 | 3.56% | -0.13pp | ₹61.89 cr |
| Increased | Alkem Laboratories Limited INE540L01014 | Pharmaceuticals & Biotechnology | 1,06,169 | +4,432 | 3.16% | +0.08pp | ₹54.82 cr |
| Increased | Zydus Lifesciences Limited INE010B01027 | Pharmaceuticals & Biotechnology | 4,36,319 | +1,378 | 2.92% | +0.05pp | ₹50.7 cr |
| Increased | Mankind Pharma Limited INE634S01028 | Pharmaceuticals & Biotechnology | 1,99,532 | +2,731 | 2.88% | +0.18pp | ₹49.96 cr |
| Increased | IPCA Laboratories Limited INE571A01038 | Pharmaceuticals & Biotechnology | 2,44,621 | +3,133 | 2.71% | — | ₹47.14 cr |
| Reduced | Biocon Limited INE376G01013 | Pharmaceuticals & Biotechnology | 12,27,131 | -13,184 | 2.62% | -0.28pp | ₹45.44 cr |
| Increased | Gland Pharma Limited INE068V01023 | Pharmaceuticals & Biotechnology | 1,40,334 | +1,810 | 2.34% | +0.07pp | ₹40.69 cr |
| Increased | Sai Life Sciences Limited INE570L01029 | Pharmaceuticals & Biotechnology | 2,43,541 | +3,671 | 2.14% | +0.15pp | ₹37.13 cr |
| Increased | Wockhardt Limited INE049B01025 | Pharmaceuticals & Biotechnology | 1,45,451 | +1,890 | 1.77% | +0.23pp | ₹30.78 cr |
| Increased | Ajanta Pharma Limited INE031B01049 | Pharmaceuticals & Biotechnology | 80,268 | +7,039 | 1.67% | +0.17pp | ₹29.06 cr |
| Increased | Abbott India Limited INE358A01014 | Pharmaceuticals & Biotechnology | 9,176 | +121 | 1.43% | +0.10pp | ₹24.89 cr |
| Increased | Piramal Pharma Limited INE0DK501011 | Pharmaceuticals & Biotechnology | 10,93,760 | +12,478 | 1.30% | -0.02pp | ₹22.59 cr |
Cash & other
| Triparty Repo | 0.18% | ₹3.16 cr |
| Cash Margin - CCIL | 0.00% | ₹0.02 cr |
| Net Current Assets | -0.12% | ₹-2.55 cr |